Name | 1,5-dihydro-4,1-benzoxazepin-2-one |
---|---|
Synonyms |
3,5-Dihydrobenzo[e][1,4]oxazepin-2(1H)-one
1,5-dihydro-benzo[e][1,4]oxazepin-2-one 3,5-Dihydro-4,1-benzoxazepin-2(1H)-on 1,5-dihydro-4,1-benzoxazepin-2(3H)-one QC-8827 |
Molecular Formula | C9H9NO2 |
---|---|
Molecular Weight | 163.17300 |
Exact Mass | 163.06300 |
PSA | 41.82000 |
LogP | 1.24040 |
HS Code | 2934999090 |
---|
~66% 3693-08-1 |
Literature: NEUROCRINE BIOSCIENCES, INC. Patent: WO2008/124614 A1, 2008 ; Location in patent: Page/Page column 42-43 ; WO 2008/124614 A1 |
~% 3693-08-1 |
Literature: Bristol-Myers Squibb Company Patent: US2007/93470 A1, 2007 ; Location in patent: Page/Page column 62 ; US 20070093470 A1 |
~% 3693-08-1 |
Literature: Testa,E.; Fontanella,L. Farmaco, Edizione Scientifica, 1965 , vol. 20, p. 323 - 335 |
Precursor 1 | |
---|---|
DownStream 0 |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |